Revascularization

In patients with complex peripheral artery disease, a drug-coated balloon performed similarly to how it did in the general PAD population, according to new data from the IN.PACT Global registry.

Among patients with critical limb ischemia, nearly two-thirds did not have revascularization or angiography before undergoing major amputation, researchers reported at VIVA 21.

Among patients with critical limb ischemia, nearly two-thirds did not have revascularization or angiography before undergoing major amputation, researchers reported at VIVA 21.

Among patients who underwent peripheral endovascular intervention, outcomes were similar between Black and white adults, though Black patients were less likely to have subsequent revascularization, according to data presented at VIVA 21.

In patients with chronic coronary disease, the beneficial effects of colchicine were consistent regardless of history of ACS and time of treatment following ACS, according to new data from the LoDoCo2 trial.

Janssen Pharmaceuticals announced that the FDA has granted an expanded indication to rivaroxaban, now allowing it for use in patients who had recent lower-extremity revascularization due to symptomatic peripheral artery disease.

For patients with STEMI and multivessel CAD, complete revascularization reduced major CV events regardless of whether the primary mode of reperfusion was pharmacoinvasive or primary PCI, according to new data from the COMPLETE trial.

In a cohort of patients with renal impairment who underwent peripheral revascularization, rivaroxaban reduced the primary composite endpoint, driven by a marked reduction in limb events, according to data from the VOYAGER PAD trial.

Fractional flow reserve-guided strategy vs. angiography-guided strategy for PCI in patients with STEMI and multivessel disease.

Endovascular intervention conferred less in-hospital mortality but more postprocedural complications compared with surgical revascularization in patients with peripheral artery disease due to chronic total occlusion, new data suggest.